Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-09

Clinical Trial Update: Clinical Study of Induced Pluripotent Stem Cells Derived Motor Neuron Precursor Cell Therapy for Amyotrophic Lateral Sclerosis (ALS) [NA]

View source ↗

Summary

A recruiting clinical trial is evaluating an induced pluripotent stem cell–derived motor neuron precursor cell therapy for amyotrophic lateral sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Induced pluripotent stem cell-derived motor neuron precursor cell therapy (induced pluripotent stem cell-derived motor neuron precursor cells)

Snippet

Sponsor: Shanghai East Hospital | Conditions: ALS | NA | Status: RECRUITING